Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa;Impact au niveau de la population de la contraception hormonale sur l'incidence de l'infection par le VIH et sur la grossesse chez des femmes de Durban, en Afrique du Sud

Bulletin of the World Health Organization

Volumn 90, Issue 10, 2012, Pages 748-755

  Ramjee, Gita ^a   Wand, Handan ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARRAGEENAN; CONTRACEPTIVE AGENT; PRO 2000;

CONTRACEPTIVE USE; DISEASE CONTROL; DISEASE INCIDENCE; DISEASE TRANSMISSION; HEALTH IMPACT; HEALTH RISK; HUMAN IMMUNODEFICIENCY VIRUS; PREGNANCY; WOMENS HEALTH;

ADULT; ARTICLE; COHORT ANALYSIS; CONDOM; FEMALE; HEALTH EDUCATION; HORMONAL CONTRACEPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PREGNANCY; PREGNANCY RATE; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEROCONVERSION; SEXUAL BEHAVIOR; SOUTH AFRICA;

ADULT; AGE DISTRIBUTION; ANTI-INFECTIVE AGENTS; CONTRACEPTIVES, ORAL, HORMONAL; EDUCATIONAL STATUS; FEMALE; HIV INFECTIONS; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HIV-1; HUMANS; INCIDENCE; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SEXUAL BEHAVIOR; SOUTH AFRICA; YOUNG ADULT;

DURBAN; KWAZULU-NATAL; SOUTH AFRICA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84867136847     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.105700     Document Type: Article

References (31)

1. Report on the global AIDS epidemic 2010. Geneva: Joint United Nations Programme on HIV/AIDS; 2010.
2. 2008 National antenatal sentinel HIV and syphilis prevalence survey, South Africa. Pretoria: National Department of Health; 2009.
3. Harrison A, Cleland J, Frohlich J. Young people's sexual partnerships in KwaZulu-Natal, South Africa: patterns, contextual influences, and HIV risk. Stud Fam Plann 2008;39:295-308. doi:10.1111/j.1728-4465.2008.00176.x PMID:19248716
4. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007;370:251-61. doi:10.1016/S0140-6736(07)60950-7 PMID:17631387
5. McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet 2010;376:1329-37. doi:10.1016/S0140-6736(10)61086-0 PMID:20851460
6. Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos M, Friedland B et al. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1977-87. doi:10.1016/S0140-6736(08)61842-5 PMID:19059048
7. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland R, Mandaliya K. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007;21:1771-7. doi:10.1097/ QAD.0b013e328270388a PMID:17690576
8. Seiber EE, Bertrand JT, Sullivan TM. Changes in contraceptive method mix in developing countries. Int Fam Plan Perspect 2007;33:117-23. doi:10.1363/3311707 PMID:17938094
9. Curtis KM, Chrisman CE, Mohllajee AP, Peterson HB. Effective use of hormonal contraceptives: part I: combined oral contraceptive pills. Contraception 2006;73:115-24. doi:10.1016/j.contraception.2005.08.003 PMID:16413842
10. Chrisman CE, Curtis KM, Mohllajee AP, Gaffield ME, Peterson HB. Effective use of hormonal contraceptives: part II: combined hormonal injectables, progestogen-only injectables and contraceptive implants. Contraception 2006;73:125-33. doi:10.1016/j.contraception.2005.08.004 PMID:16413843
11. Reynolds HW, Steiner MJ, Cates W. Contraception's proved potential to fight HIV. Sex Transm Infect 2005;81:184-5. doi:10.1136/sti.2004.012013 PMID:15800107
12. Martin HL, Nyange PM, Richardson BA, Lavreys L, Mandaliya K, Jackson DJ et al. Hormonal contraception, sexually transmitted diseases, and risk of heterosexual transmission of human immunodeficiency virus type 1. J Infect Dis 1998;178:1053-9. doi:10.1086/515654 PMID:9806034
13. Bulterys M, Smith D, Chao A, Jaffe H. Hormonal contraception and incident HIV-1 infection: New insight and continuing challenges. AIDS 2007;21:97-9. doi:10.1097/QAD.0b013e3280117cb5 PMID:17148973
14. Morrison CS, Pai-Lien C, Cynthia K, Richardson BA, Chipato T, Mugerwa R et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010;24:1778. doi:10.1097/ QAD.0b013e32833a2537 PMID:20588106
15. Baeten JM, Lavreys L, Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007;45:360-9. doi:10.1086/519432 PMID:17599316
16. Kiddugavu M, Makumbi F, Wawer MJ, Serwadda D, Sewankambo NK, Wabwire-Mangen F et al. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda. AIDS 2003;17:233. doi:10.1097/00002030-200301240-00014 PMID:12545084
17. Kleinschmidt I, Rees H, Delany S, Smith D, Dinat N, Nkala B et al. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort. Contraception 2007;75:461-7. doi:10.1016/j. contraception.2007.02.002 PMID:17519153
18. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E et al. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012;12:19-26. doi:10.1016/S1473-3099(11)70247-X PMID:21975269
19. Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 2012;26:375-80. doi:10.1097/QAD.0b013e32834f990f PMID:22156970
20. Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS 2012;26:497. doi:10.1097/QAD.0b013e32834fa13d PMID:22156973
21. Hormonal contraception and HIV (Technical Statement). Geneva: World Health Organization; 2012.
22. Davis KR, Weller SC. The effectiveness of condoms in reducing heterosexual transmission of HIV. Fam Plann Perspect 1999;31:272-9. doi:10.2307/2991537 PMID:10614517
23. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev 2002;1:CD003255. PMID:11869658
24. Wand H, Ramjee G. Combined impact of sexual risk behaviors for HIV seroconversion among women in Durban, South Africa: Implications for prevention policy and planning. AIDS Behav 2011;15:479-86. doi:10.1007/s10461-010-9845-2 PMID:20981479
25. Ramjee G, Williams B, Gouws E, Van Dyck E, Deken B, Karim S. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr 2005;39:333. doi:10.1097/01.qai.0000144445.44518.ea PMID:15980695
26. Spiegelman D, Hertzmark E, Wand H. Point and interval estimates of partial population attributable risks in cohort studies: examples and software. Cancer Causes Control 2007;18:571-9. doi:10.1007/s10552-006-0090-y PMID:17387622
27. Wand H, Spiegelman D, Law M, Jalaludin B, Kaldor J, Maher L. Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning. Addiction 2009;104:2049-56. doi:10.1111/j.1360-0443.2009.02704.x PMID:19804463
28. Ramjee G, Wand H, Whitaker C, McCormack S, Padian N, Kelly C et al. HIV incidence among non-pregnant women living in selected rural, semi-rural and urban areas in Kwazulu-Natal, South Africa. AIDS Behav 2011:Epub 2011 Sep 25. PMID:21947836
29. Mostad SB, Overbaugh J, DeVange DM, Welch MJ, Chohan B, Mandaliya K et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997;350:922-7. doi:10.1016/S0140-6736(97)04240-2 PMID:9314871
30. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007;36:166-74. doi:10.1093/ije/dyl251 PMID:17175547
31. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:500-7. doi:10.1097/00042560-199608150-00010 PMID:8757428